LIBRETTO-432, a phase III study of adjuvant selpercatinib or placebo in stage IB-IIIA RET fusion-positive non-small-cell lung cancer

Authors: Tsuboi, Masahiro, Goldman, Jonathan W, Wu, Yi-Long, Johnson, Melissa L, Paz-Ares, Luis, Yang, James Chih-Hsin, Besse, Benjamin, Su, Weiji, Chao, Bo H, Drilon, Alexander

Source: Future oncology. 18(28):3133-3141

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100191695707.0x000001&indx=1&recIds=ETOCvdc_100191695707.0x000001

Phase 1 Expansion Cohort of Ramucirumab Plus Pembrolizumab in Advanced Treatment-Naive NSCLC

Authors: Herbst, Roy S., Arkenau, Hendrik Tobias, Bendell, Johanna, Arrowsmith, Edward, Wermke, Martin, Soriano, Andres, Penel, Nicolas, Santana-Davila, Rafael, Bischoff, Helge, Chau, Ian, Mi, Gu, Wang, Hong, Rasmussen, Erik, Ferry, David, Chao, Bo H., Paz-Ares, Luis

Source: In Journal of Thoracic Oncology February 2021 16(2):289-298

FIR: Efficacy, Safety, and Biomarker Analysis of a Phase II Open-Label Study of Atezolizumab in PD-L1–Selected Patients With NSCLC

Authors: Spigel, David R., Chaft, Jamie E., Gettinger, Scott, Chao, Bo H., Dirix, Luc, Schmid, Peter, Chow, Laura Q.M., Hicks, Rodney J., Leon, Larry, Fredrickson, Jill, Kowanetz, Marcin, Sandler, Alan, Funke, Roel, Rizvi, Naiyer A.

Source: In Journal of Thoracic Oncology November 2018 13(11):1733-1742

Alectinib in ALK-positive, crizotinib-resistant, non-small-cell lung cancer: a single-group, multicentre, phase 2 trial

Authors: Shaw, Alice T, Gandhi, Leena, Gadgeel, Shirish, Riely, Gregory J, Cetnar, Jeremy, West, Howard, Camidge, D Ross, Socinski, Mark A, Chiappori, Alberto, Mekhail, Tarek, Chao, Bo H, Borghaei, Hossein, Gold, Kathryn A, Zeaiter, Ali, Bordogna, Walter, Balas, Bogdana, Puig, Oscar, Henschel, Volkmar, Ou, Sai-Hong Ignatius

Source: In The Lancet Oncology February 2016 17(2):234-242

Epidermal growth factor receptor (EGFR) mutations in small cell lung cancers: Two cases and a review of the literature

Authors: Siegele, Bradford J., Shilo, Konstantin, Chao, Bo H., Carbone, David P., Zhao, Weiqiang, Ioffe, Olga, Franklin, Wilbur A., Edelman, Martin J., Aisner, Dara L.

Source: Lung cancer. 95:65-72

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100032283910.0x000001&indx=1&recIds=ETOCvdc_100032283910.0x000001

Case Report: Complete pathologic response to neoadjuvant selpercatinib in a patient with resectable early-stage RET fusion-positive non-small cell lung cancer.

Authors: Goldman, Jonathan W., Sholl, Lynette M., Dacic, Sanja, Fishbein, Michael C., Murciano-Goroff, Yonina R., Rajaram, Ravi, Szymczak, Sylwia, Szpurka, Anna M., Chao, Bo H., Drilon, Alexander

Source: Frontiers in Oncology; 2023, p1-5, 5p

Randomized Phase 2 Studies of Checkpoint Inhibitors Alone or in Combination With Pegilodecakin in Patients With Metastatic NSCLC (CYPRESS 1 and CYPRESS 2)

Authors: Spigel, David, Jotte, Robert, Nemunaitis, John, Shum, Merrill, Schneider, Jeffrey, Goldschmidt, Jerome, Eisenstein, Jennifer, Berz, David, Seneviratne, Lasika, Socoteanu, Matei, Bhanderi, Viralkumar, Konduri, Kartik, Xia, Meng, Wang, Hong, Hozak, Rebecca R., Gueorguieva, Ivelina, Ferry, David, Gandhi, Leena, Chao, Bo H., Rybkin, Igor

Source: In Journal of Thoracic Oncology February 2021 16(2):327-333

LIBRETTO-432, a phase III study of adjuvant selpercatinib or placebo in stage IB-IIIA fusion-positive non-small-cell lung cancer.

Authors: Tsuboi, Masahiro, Goldman, Jonathan W, Wu, Yi-Long, Johnson, Melissa L, Paz-Ares, Luis, Yang, James Chih-Hsin, Besse, Benjamin, Su, Weiji, Chao, Bo H, Drilon, Alexander

Source: Future Oncology; Sep2022, Vol. 18 Issue 27, p3133-3141, 9p

Subject Terms: LUNG cancer, PROTEINS, PYRIDINE, ADJUVANT chemotherapy, CLINICAL trials, HETEROCYCLIC compounds, PROTEIN kinase inhibitors, LUNG tumors, CANCER relapse, TUMOR classification, RESEARCH funding

Pre-treatment inflammation induced by TNF-α augments cryosurgical injury on human prostate cancer

Authors: Chao, Bo H., He, Xiaoming, Bischof, John C.

Source: In Cryobiology 2004 49(1):10-27

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.